Prephase steroid use and association with dose delays and outcomes in a real-world cohort of older adults treated for diffuse large B-cell lymphoma

被引：0
|
作者：
Vartanov, Alexander R. [1 ]
Hasler, Jill S. [2 ]
Handorf, Elizabeth A. [2 ,3 ]
Frosch, Zachary A. K. [4 ,5 ]
机构：
[1] Fox Chase Canc Ctr, Dept Bone Marrow Transplant & Cellular Therapy, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA USA
[3] Rutgers Sch Publ Hlth, Biostat & Epidemiol Facil, Piscataway, NJ USA
[4] Fox Chase Canc Ctr, Dept Hematol Oncol, Philadelphia, PA USA
[5] Fox Chase Canc Ctr, Canc Prevent & Control Res Program, Philadelphia, PA USA
来源：
LEUKEMIA & LYMPHOMA | 2025年
关键词：
ELDERLY-PATIENTS; R-CHOP; CHEMOTHERAPY; INTENSITY; TRIAL;
D O I：
10.1080/10428194.2025.2450091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China
    Wang, Shuo
    Wang, Li
    Hu, Jianda
    Qian, Wenbin
    Zhang, Xi
    Hu, Yu
    Zhu, Qi
    Chen, Bobin
    Wu, Depei
    Chang, Chung-Chou H.
    Xu, Pengpeng
    Zheng, Xiaoyun
    Wei, Juying
    Liu, Yao
    Cui, Guohui
    Tang, Yong
    Ma, Yan
    Huang, Haiwen
    Yi, Hongmei
    Zhao, Weili
    CANCER COMMUNICATIONS, 2021, 41 (03) : 229 - 239
  • [22] Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection
    Yang, Wanxi
    Zhao, Xue
    Ma, Hongbing
    Xu, Caigang
    INFECTIOUS AGENTS AND CANCER, 2024, 19 (01):
  • [23] Efficacy and safety of orelabrutinib in diffuse large B-cell lymphoma: A real-world analysis.
    Xu, Peng-Peng
    Liu, Tingbo
    Li, Zengjun
    Li, Zheng
    Huang, Wei
    Zhou, Keshu
    Cai, Mingci
    Shen, Rong
    Zhao, Weili
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
    Upshaw, Jenica N.
    Nelson, Jason
    Rodday, Angie Mae
    Kumar, Anita J.
    Klein, Andreas K.
    Konstam, Marvin A.
    Wong, John B.
    Jaffe, Iris Z.
    Ky, Bonnie
    Friedberg, Jonathan W.
    Maurer, Matthew
    Kent, David M.
    Parsons, Susan K.
    JAMA CARDIOLOGY, 2023, 8 (05) : 453 - 461
  • [25] Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma
    Nowakowski, Grzegorz
    Maurer, Matthew J.
    Cerhan, James R.
    Dey, Debarshi
    Sehn, Laurie H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 180 - 192
  • [26] Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma
    Wang, Xiaoyan
    Yu, Lu
    Jiang, Xinlu
    Ding, Kaiyang
    CANCER MEDICINE, 2023, 12 (09): : 10553 - 10562
  • [27] Real-World Outcomes of Patients with Diffuse Large B-Cell Lymphoma Receiving Second Line Therapy in the United States
    Sawas, Ahmed
    Lau, Constance
    Thomson, Michael
    Maignan, Kathleen
    BLOOD, 2020, 136
  • [28] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Andrew Ip
    Alex Mutebi
    Tongsheng Wang
    Monika Jun
    Anupama Kalsekar
    Fernando Rivas Navarro
    Anthony Wang
    Rajesh Kamalakar
    Mariana Sacchi
    Brian Elliott
    Advances in Therapy, 2024, 41 : 1226 - 1244
  • [29] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    ADVANCES IN THERAPY, 2024, 41 (03) : 1226 - 1244
  • [30] Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population
    Byun, Ja Min
    Lee, Jeong-Ok
    Kang, Beodeul
    Kim, Ji-Won
    Kim, Se Hyun
    Kim, Jin Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Bang, Soo-Mee
    Lee, Jong Seok
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 503 - 510
12345